National Association of Testing Authorities, Australia
Scope of Accreditation
NSW Health Pathology
Site
NSW Health Pathology Lismore Hospital Laboratory
Accreditation No.
2710
Site No.
2703
Date of Accreditation
21 Aug 1989
Address
Ground Level, Lismore Hospital, 60 Hunter Street
Lismore, NSW 2480
Australia
Contact
Mr Christopher Nicol P: +61 (02) 66202914
Availability
Services available to external clients
Supervision
B (Branch)
Scope of Accreditation
NSW Health Pathology Lismore Hospital Laboratory
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
18 Apr 2027
Last Activity Date
05 Dec 2023
| Service | Product | Determinant |
|---|---|---|
| Immunohaematology - Investigation of blood transfusion reactions | Blood; Blood products | Antibodies; Contamination - Microbiological; Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
18 Apr 2027
Last Activity Date
05 Dec 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma; Serum | Paracetamol (acetaminophen) |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma; Serum | Carbamazepine; Digoxin; Ethanol; Gentamicin (cidomycin, septopal, genticyn, garamycin); Lithium; Phenytoin (dilantin); Salicylate; Valproate (valproic acid, epilim); Vancomycin |
| Chemical pathology - Detection and/or quantitation of tumour markers | Plasma; Serum | CA125 antigen (CA125); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); α-Fetoprotein (AFP) |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma; Serum | Procalcitonin |
| Serum | Cortisol; Follicle stimulating hormone (FSH); Luteinising hormone (LH); Oestradiol; Parathyroid hormone (PTH); Progesterone; Prolactin | |
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Glycated haemoglobin (HbA1c) | ||
| Chemical pathology - Further investigation of cardiac function | Blood | B-type natriuretic peptide (BNP); Troponin I |
| Plasma; Serum | N-Terminal-pro b-type natriuretic peptide (NT-proBNP); Troponin | |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | HDL - Quantitation |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum; Urine | Uric acid |
| Serum | Haptoglobins | |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Calcium - Ionised; Chloride; Creatinine; Glucose; Potassium; Sodium; Total carbon dioxide (TCO2); Urea |
| Cerebrospinal fluid (CSF) | Glucose; Lactate; Protein - Total | |
| Drainage fluid; Peritoneal fluid; Pleural fluid | Albumin; Amylase; Bilirubin - Total; Cholesterol - Total; Glucose; Lactate dehydrogenase (LDH); Lipase; Protein - Total; Triglycerides; Urate | |
| Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Ammonia; Amylase; Aspartate aminotransferase; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Carbon dioxide (CO2); Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urea; γ-Glutamyltransferase | |
| Plasma; Serum; Urine | Osmolality | |
| Urine | Albumin; Calcium - Total; Chloride; Creatinine; Glucose; Phosphate; Potassium; Protein - Total; Sodium; Urea | |
| Chemical pathology - Investigation for folate deficiency | Plasma; Serum | Folate |
| Chemical pathology - Iron studies | Plasma; Serum | Iron; Transferrin |
| Ferritin | ||
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Total carbon dioxide (TCO2); pH |
| Chemical pathology - Quantitation of vitamins | Plasma; Serum | 25-Hydroxyvitamin D3; Cobalamin (vitamin B12) |
| Chemical pathology - Tests for thyroid function | Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Presence of foetal red blood cells |
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Reticulocytes |
| Morphology | ||
| Haematocrit (packed cell volume, PCV) | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR); Prothrombin time (PT) |
| Plasma | Activated partial thromboplastin time (APTT); Activated partial thromboplastin time heparin resistant (aPTT-HR); Anti-Xa - Apixaban; Anti-Xa - Rivaroxaban; Anti-Xa activity - Clexane - Low molecular weight heparin; Anti-Xa activity - Low molecular weight heparin; Anti-Xa activity - Unfractionated heparin; D-dimer; Fibrinogen; International normalised ratio (INR); Prothrombin time (PT); Thrombin time (TT) | |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunohaematology - Blood group antibody detection | Blood; Plasma | Duffy system; Kell system; M and N factors; Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood; Plasma | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood; Plasma | Direct antiglobulin test (DAT, direct Coombs test); Electronic crossmatch; Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies; Indirect antiglobulin test (IAT) |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody elution |
| Blood; Plasma | Other blood group antibodies; Red blood cell phenotyping; Rh | |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Blood; Faeces; Fluids; General swabs; Genital swabs; Sputum; Synovial fluid; Urine | Bacteria; Pathogenic identification and antibiotic susceptibility |
| Bacteria; Pathogenic identification and antibiotic susceptibility | ||
| Bacteria; Pathogenic identification and antibiotic susceptibility | ||
| Bacteria; Pathogenic microorganisms | ||
| Aspirates; Blood; General swabs; Genital swabs; Sputum; Synovial fluid; Urine | Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Blood | Bacteria; Pathogenic microorganisms | |
| Urine | Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Legionella antigen; Streptococcus pneumoniae antigen | ||
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Blood transfusion bags; Gastrointestinal endoscopes; Vascular catheter tips | Bacterial growth - Sterility |
| Dialysis waters | Bacterial growth - Sterility | |
| Bacterial growth - Sterility | ||
| Environmental swabs | Bacterial organism identification - Acinetobacter; Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE) | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Blood culture | Methicillin resistant Staphylococcus aureus (MRSA) |
| Bronchial washings; Nasal swabs; Throat swabs | Bordetella pertussis; Mycoplasma pneumoniae | |
| Faeces | Clostridioides difficile | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Bronchial washings; Bronchoalveolar lavage; Endotrachael aspirate; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Serum; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Bronchial washings; Bronchoalveolar lavage; Endotrachael aspirate; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Throat swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | |
| Bronchial washings; Nasal swabs; Throat swabs | Adenovirus; Enterovirus; Human metapneumovirus; Human parechovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3; Picornavirus; Respiratory syncytial virus (RSV) | |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Sputum | Mycobacteria identification |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Faeces | Cysts; Ova; Parasites | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Infectious mononucleosis |
| Serum | Syphilis Treponema pallidum antibody | |
| Hepatitis A virus antibody (anti-HAV) - IgG; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus antibody (anti-HCV); Human immunodeficiency virus (HIV) p24 antigen; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Rubella IgG antibody; Syphilis Treponema pallidum antibody |
C6 CCU
ISO 15189 (2022)
Human Pathology
Medicare expiry date
18 Apr 2027
Last Activity Date
05 Dec 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Community Health Diabetes
ISO 15189 (2022)
Human Pathology
Medicare expiry date
18 Apr 2027
Last Activity Date
05 Dec 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Emergency Department
ISO 15189 (2022)
Human Pathology
Medicare expiry date
18 Apr 2027
Last Activity Date
05 Dec 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Creatinine; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
F8 Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
18 Apr 2027
Last Activity Date
05 Dec 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Imaging
ISO 15189 (2022)
Human Pathology
Medicare expiry date
18 Apr 2027
Last Activity Date
05 Dec 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Creatinine |
Operating Theatre
ISO 15189 (2022)
Human Pathology
Medicare expiry date
18 Apr 2027
Last Activity Date
05 Dec 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Short Stay Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
18 Apr 2027
Last Activity Date
05 Dec 2023
| Service | Product | Determinant |
|---|---|---|
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR); Prothrombin time (PT) |
Special Care Nursery
ISO 15189 (2022)
Human Pathology
Medicare expiry date
18 Apr 2027
Last Activity Date
05 Dec 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Glucose |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Total carbon dioxide (TCO2); pH |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2710
Site No.
2703
Print date
26 Dec 2024
END OF SCOPE